Gene description for ADAM28 |
Gene name |
ADAM metallopeptidase domain 28 |
Gene symbol |
ADAM28 |
Other names/aliases |
ADAM 28 MDC-L MDCL eMDC II eMDCII |
Species |
Homo sapiens |
Database cross references - ADAM28 |
ExoCarta |
ExoCarta_10863 |
Vesiclepedia |
VP_10863 |
Entrez Gene |
10863 |
HGNC |
206 |
MIM |
606188 |
UniProt |
Q9UKQ2
|
ADAM28 identified in exosomes derived from the following tissue/cell type |
Pancreatic duct fluid
|
29339034
|
Pancreatic duct fluid
|
29339034
|
Pancreatic duct fluid
|
29339034
|
Gene ontology annotations for ADAM28 |
|
Experiment description of studies that identified ADAM28 in exosomes |
1 |
Experiment ID |
622 |
MISEV standards |
✔
EM
|
Biophysical techniques |
|
Enriched markers |
✔
GOLGA2|CYC1
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
Protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
29339034
|
Organism |
Homo sapiens |
Experiment description |
Extracellular matrix proteins and carcinoembryonic antigen-related cell adhesion molecules characterize pancreatic duct fluid exosomes in patients with pancreatic cancer |
Authors |
Zheng J, Hernandez JM, Doussot A, Bojmar L, Zambirinis CP, Costa-Silva B, van Beek EJAH, Mark MT, Molina H, Askan G, Basturk O, Gonen M, Kingham TP, Allen PJ, D'Angelica MI, DeMatteo RP, Lyden D, Jarnagin WR. |
Journal name |
HPB
|
Publication year |
2018 |
Sample |
Pancreatic duct fluid |
Sample name |
From patients with Pancreatic ductal adenocarcinoma |
Isolation/purification methods |
Differential centrifugation Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
2 |
Experiment ID |
623 |
MISEV standards |
✘
|
Biophysical techniques |
|
Enriched markers |
✔
GOLGA2|CYC1
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
Protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
29339034
|
Organism |
Homo sapiens |
Experiment description |
Extracellular matrix proteins and carcinoembryonic antigen-related cell adhesion molecules characterize pancreatic duct fluid exosomes in patients with pancreatic cancer |
Authors |
Zheng J, Hernandez JM, Doussot A, Bojmar L, Zambirinis CP, Costa-Silva B, van Beek EJAH, Mark MT, Molina H, Askan G, Basturk O, Gonen M, Kingham TP, Allen PJ, D'Angelica MI, DeMatteo RP, Lyden D, Jarnagin WR. |
Journal name |
HPB
|
Publication year |
2018 |
Sample |
Pancreatic duct fluid |
Sample name |
From patients with IPMN with microinvasive cancer (IPMNca) |
Isolation/purification methods |
Differential centrifugation Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
3 |
Experiment ID |
625 |
MISEV standards |
✘
|
Biophysical techniques |
|
Enriched markers |
✔
GOLGA2|CYC1
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
Protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
29339034
|
Organism |
Homo sapiens |
Experiment description |
Extracellular matrix proteins and carcinoembryonic antigen-related cell adhesion molecules characterize pancreatic duct fluid exosomes in patients with pancreatic cancer |
Authors |
Zheng J, Hernandez JM, Doussot A, Bojmar L, Zambirinis CP, Costa-Silva B, van Beek EJAH, Mark MT, Molina H, Askan G, Basturk O, Gonen M, Kingham TP, Allen PJ, D'Angelica MI, DeMatteo RP, Lyden D, Jarnagin WR. |
Journal name |
HPB
|
Publication year |
2018 |
Sample |
Pancreatic duct fluid |
Sample name |
From patients with benign pancreatic disease |
Isolation/purification methods |
Differential centrifugation Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
Protein-protein interactions for ADAM28 |
|
Protein Interactor |
ExoCarta ID |
Identification method |
PubMed |
Species |
No interactions are found.
|
|
Pathways in which ADAM28 is involved |
No pathways found
|
|
|